INS and breast cancer: Standardized test meal (STM), as an in-house modification of the test introduced by Pozznan et al. in 1997, was investigated at our research center to assess residual insulin secretion in T2D patients, with the assessment of C-Peptide (C-Pep) for BC response [28].